Completed PHASE4 INTERVENTIONAL NCT00375375

Effect of Lactulose on Minimal Hepatic Encephalopathy and Health-Related Quality of Life

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh

Conditions Hepatic Encephalopathy Minimal Hepatic Encephalopathy

Interventions Lactulose

Updated 6 times since 2017 Last updated: Mar 1, 2007 Started: Jan 31, 2004 Completion: Dec 31, 2004

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Hepatic Encephalopathy and Minimal Hepatic Encephalopathy and is currently completed. Post Graduate Institute of Medical Education and Research, Chandigarh leads this study, which shows 6 recorded versions since 2004 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Apr 2024 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Apr 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jan 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Post Graduate Institute of Medical Education and Research, Chandigarh

Data source: PIMERIndia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chandigarh, India